Cargando…

Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018

OBJECTIVE: Our objective was to examine perspective and costing approaches used in cost-effectiveness analyses (CEAs) and the distribution of reported incremental cost-effectiveness ratios (ICERs). METHODS: We analyzed the Tufts Medical Center’s CEA and Global Health CEA registries, containing 6907...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, David D., Silver, Madison C., Kunst, Natalia, Cohen, Joshua T., Ollendorf, Daniel A., Neumann, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373843/ https://www.ncbi.nlm.nih.gov/pubmed/32696192 http://dx.doi.org/10.1007/s40273-020-00942-2

Ejemplares similares

Correction to: Perspective and Costing in Cost‑Effectiveness Analysis, 1974–2018
por: Kim, David D., et al.
Publicado: (2020)

Should Drug Companies Engage with ICER? An Empirical Analysis of How Often Manufacturers Engage with ICER and Whether Engagement May Influence ICER’s Cost-Effectiveness Estimates
por: Breslau, Rachel Milstein, et al.
Publicado: (2022)

Growth and capacity for cost‐effectiveness analysis in Africa
por: Panzer, Ari D., et al.
Publicado: (2020)

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies
por: Leech, Ashley A., et al.
Publicado: (2018)

Cost Variation Index for 1974 - Basic and ISR Programmes
Publicado: (1973)

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs
por: Bilinski, Alyssa, et al.
Publicado: (2017)

Forecast of the Cost Variation Index for 1974 - Basic and ISR Programmes
Publicado: (1973)

1974 Budget for Laboratory I Application of the Cost Variation Index
Publicado: (1973)

Forecast of the Cost Variation Index for 1974 - Basic and ISR Programmes
Publicado: (1973)

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures
por: Neumann, Peter J., et al.
Publicado: (2018)

Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries
por: Ma, Siyu, et al.
Publicado: (2022)

Taking stock of cost-effectiveness analysis of healthcare in China
por: Butt, Thomas, et al.
Publicado: (2019)

Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis
por: Hendrix, Nathaniel, et al.
Publicado: (2018)

The impact of external reference pricing on pharmaceutical costs and market dynamics
por: Voehler, Dominic, et al.
Publicado: (2023)

2212 A systematic overview of cost-utility analyses in dermatology
por: Li, David G., et al.
Publicado: (2018)

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted
por: Neumann, Peter J., et al.
Publicado: (2016)

Policy Narratives on Palliative Care in Sweden 1974–2018
por: Ågren, Axel, et al.
Publicado: (2023)

The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients
por: Zhong, Yue, et al.
Publicado: (2016)

When are breakthrough therapies cost-effective?
por: Olchanski, Natalia, et al.
Publicado: (2022)

The Cost-Variation Index for 2018
Publicado: (2017)

Survival to Age 90 in Men: The Tromsø Study 1974–2018
por: Brenn, Tormod
Publicado: (2019)

Plague in Zimbabwe from 1974 to 2018: A review article
por: Munyenyiwa, Amon, et al.
Publicado: (2019)

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States
por: Carlson, Josh J., et al.
Publicado: (2018)

Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia
por: Goshua, George, et al.
Publicado: (2022)

Stress CMR myocardial perfusion imaging (CMR-MPI) is cost-effective compared to nuclear SPECT: a retrospective cost-effectiveness analysis
por: Francis, Sanjeev, et al.
Publicado: (2012)

Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare
por: Brent, Robert J.
Publicado: (2023)

Correction: Plague in Zimbabwe from 1974 to 2018: A review article
por: Munyenyiwa, Amon, et al.
Publicado: (2020)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Abstract: Cost-Analysis Research in Plastic Surgery: What Is the Prevalence of Underreporting Cost Perspective?
por: Blank, Madeleine M., et al.
Publicado: (2017)

Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison
por: Wolff, Henri B., et al.
Publicado: (2022)

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma
por: Whittington, Melanie D., et al.
Publicado: (2019)

Adherence to the iDSI reference case among published cost-per-DALY averted studies
por: Emerson, Joanna, et al.
Publicado: (2019)

1974 Budget for Laboratory II at 1974 Proces
Publicado: (1973)

Cost-effectiveness of tobacco control policies and programmes targeting adolescents: a systematic review
por: Leão, Teresa, et al.
Publicado: (2018)

Cost-effective Analysis of Subcutaneous vs Sublingual Immunotherapy From the Payor’s Perspective
por: Hardin, Frances Mei, et al.
Publicado: (2021)

Patient and Caregiver Views on Measures of the Value of Health Interventions
por: Voehler, Dominic, et al.
Publicado: (2022)

Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy
por: Kim, David D.
Publicado: (2023)

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
por: Yang, Szu-Chun, et al.
Publicado: (2021)

Examining US commercial health plans’ use of The Institute for Clinical and Economic Review’s reports in specialty drug coverage decisions
por: Chambers, James D, et al.
Publicado: (2023)

Cost Variation Index for 1975 Basic and ISR Programmes Motion Adopted by the Extraordinary General Assembly of the Staff on 16 December 1974
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_lcu58ug7ddee8aqlrf21mpc9ej